From: Blood transfusion in deceased donor kidney transplantation
All patients ( n=306) | Warfarin ( n=14) | Antiplatelet agents ( n=136) | No anticoagulant ( n=156) | Probability | |
---|---|---|---|---|---|
Age (years) | 51 ± 13 | 50 ± 10 | 55 ± 11 | 48 ± 13 | <0.001 |
Male gender | 186 (61) | 10 (71) | 93 (68) | 83 (53) | 0.021 |
Diabetes mellitus (%) | 72 (24) | 1 (7.1) | 56 (41) | 15 (9.6) | <0.001 |
cPRA (%) | 16 ± 28 | 14 ± 29 | 14 ± 26 | 18 ± 30 | 0.484 |
HLA MM | 4.1 ± 1.4 | 3.4 ± 1.6 | 4.2 ± 1.2 | 4.2 ± 1.2 | 0.082 |
CIT (h) | 13.1 ± 10.8 | 12.4 ± 6.1 | 14.2 ± 14.4 | 11.8 ± 6.2 | 0.084 |
Donor age (years) | 48 ± 17 | 52 ± 17 | 51 ± 15 | 45 ± 17 | 0.006 |
Donor gender male | 136 (44) | 6 (43) | 62 (46) | 68 (44) | 0.936 |
Hb pre g/L | 119 ± 14 | 122 ± 14 | 119 ± 14 | 119 ± 14 | 0.658 |
INR | 1.03 ± 0.22 | 1.89 ± 0.36 | 0.99 ± 0.10 | 0.98 ± 0.08 | <0.001 |
Platelet count | 230 ± 77 | 230 ± 94 | 233 ± 85 | 227 ± 70 | 0.828 |
Transfusion (%) | 80 (26) | 8 (57) | 46 (33.8) | 26 (16.7) | <0.001 |
Units total (units/patient) | 300 (0.98) | 71 (5.1) | 155 (1.14) | 74 (0.47) | <0.001 |
Hb nadir g/L | 83 ± 15 | 77 ± 23 | 81 ± 14 | 85 ± 14 | 0.018 |
Length of hospital stay (days) | 12.5 ± 10.2 | 18.7 ± 13.7 | 13.9 ± 12.9 | 10.6 ± 5.9 | 0.001 |